questionsmedicales.fr
Eucaryotes
Champignons
Deuteromycota
Chrysosporium
Chrysosporium : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Infections fongiques
Mycologie
Culture des champignons
PCR
Biopsie
Infections fongiques
Symptômes
Infections fongiques
Tests sérologiques
Infections fongiques
Symptômes
5
Symptômes
Infections fongiques
Infections cutanées
Chrysosporium
Infections pulmonaires
Symptômes
Infections systémiques
Chrysosporium
Prévention
5
Prévention
Infections fongiques
Immunodépression
Prévention
Prévention
Infections fongiques
Traitements
5
Antifongiques
Chrysosporium
Traitement
Infections fongiques
Durée du traitement
Antifongiques
Effets secondaires
Antifongiques
Hospitalisation
Infections fongiques
Complications
5
Complications
Infections fongiques
Mortalité
Infections fongiques
Gestion des complications
Antifongiques
Infections récurrentes
Immunodépression
Facteurs de risque
5
Facteurs de risque
Immunodépression
Personnes âgées
Facteurs de risque
Diabète
Infections fongiques
Immunosuppresseurs
Facteurs de risque
Voyages
Infections fongiques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Chrysosporium : Questions médicales les plus fréquentes",
"headline": "Chrysosporium : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Chrysosporium : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-07",
"dateModified": "2025-05-02",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Chrysosporium"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Deuteromycota",
"url": "https://questionsmedicales.fr/mesh/D003904",
"about": {
"@type": "MedicalCondition",
"name": "Deuteromycota",
"code": {
"@type": "MedicalCode",
"code": "D003904",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.300.381"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Chrysosporium",
"alternateName": "Chrysosporium",
"code": {
"@type": "MedicalCode",
"code": "D002912",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Anwei Chen",
"url": "https://questionsmedicales.fr/author/Anwei%20Chen",
"affiliation": {
"@type": "Organization",
"name": "College of Resources and Environment, Hunan Agricultural University, Changsha 410128, PR China. Electronic address: A.Chen@hunau.edu.cn."
}
},
{
"@type": "Person",
"name": "Liang Hu",
"url": "https://questionsmedicales.fr/author/Liang%20Hu",
"affiliation": {
"@type": "Organization",
"name": "School of Minerals Processing and Bioengineering, Key Laboratory of Biohydrometallurgy of Ministry of Education, Central South University, Changsha 410083, China. Electronic address: huliang2018@csu.edu.cn."
}
},
{
"@type": "Person",
"name": "Sheng-Tao Yang",
"url": "https://questionsmedicales.fr/author/Sheng-Tao%20Yang",
"affiliation": {
"@type": "Organization",
"name": "College of Chemistry and Environment Protection Engineering, Southwest Minzu University, Chengdu, 610041, PR China. Electronic address: yangst@pku.edu.cn."
}
},
{
"@type": "Person",
"name": "Ni He",
"url": "https://questionsmedicales.fr/author/Ni%20He",
"affiliation": {
"@type": "Organization",
"name": "School of Minerals Processing and Bioengineering, Key Laboratory of Biohydrometallurgy of Ministry of Education, Central South University, Changsha 410083, China."
}
},
{
"@type": "Person",
"name": "Motoyuki Shimizu",
"url": "https://questionsmedicales.fr/author/Motoyuki%20Shimizu",
"affiliation": {
"@type": "Organization",
"name": "Department of Applied Biological Chemistry, Faculty of Agriculture, Meijo University, Nagoya, Aichi 468-8502, Japan. Electronic address: moshimi@meijo-u.ac.jp."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "4-Thioribose Analogues of Adenosine Diphosphate Ribose (ADPr) Peptides.",
"datePublished": "2023-06-20",
"url": "https://questionsmedicales.fr/article/37338412",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acs.orglett.3c01554"
}
},
{
"@type": "ScholarlyArticle",
"name": "Utilization Trends In Platelet Adenosine Diphosphate P2Y12 Receptor Inhibitor and Cost Among Medicare Beneficiaries.",
"datePublished": "2023-01-20",
"url": "https://questionsmedicales.fr/article/36690313",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cpcardiol.2023.101608"
}
},
{
"@type": "ScholarlyArticle",
"name": "Impact of Oral Anticoagulation and Adenosine Diphosphate Inhibitor Therapies on Short-term Outcome of Traumatic Brain Injury.",
"datePublished": "2022-06-28",
"url": "https://questionsmedicales.fr/article/35764401",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1212/WNL.0000000000200834"
}
},
{
"@type": "ScholarlyArticle",
"name": "Selective turn-on sensing of adenosine diphosphate and phosphate anions by ruthenium (II) polypyridine anchored p-tert-butylcalix[4]arene platform.",
"datePublished": "2023-10-02",
"url": "https://questionsmedicales.fr/article/37804708",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.saa.2023.123483"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Combination therapy with poly(adenosine diphosphate-ribose) polymerase (PARPi) and androgen receptor signaling pathway (ARPi) inhibitors for metastatic castration-resistant prostate cancer].",
"datePublished": "2023-11-17",
"url": "https://questionsmedicales.fr/article/37978072",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00120-023-02230-1"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Eucaryotes",
"item": "https://questionsmedicales.fr/mesh/D056890"
},
{
"@type": "ListItem",
"position": 3,
"name": "Champignons",
"item": "https://questionsmedicales.fr/mesh/D005658"
},
{
"@type": "ListItem",
"position": 4,
"name": "Deuteromycota",
"item": "https://questionsmedicales.fr/mesh/D003904"
},
{
"@type": "ListItem",
"position": 5,
"name": "Chrysosporium",
"item": "https://questionsmedicales.fr/mesh/D002912"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Chrysosporium - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Chrysosporium",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Chrysosporium",
"description": "Comment diagnostiquer une infection par Chrysosporium ?\nQuels tests sont utilisés pour identifier Chrysosporium ?\nLes biopsies sont-elles nécessaires pour le diagnostic ?\nQuels symptômes indiquent une infection par Chrysosporium ?\nPeut-on utiliser des tests sérologiques pour le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D002912?mesh_terms=Adenosine+Diphosphate#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Chrysosporium",
"description": "Quels sont les symptômes courants d'une infection fongique ?\nLes infections cutanées par Chrysosporium sont-elles fréquentes ?\nComment se manifestent les infections pulmonaires ?\nLes infections systémiques sont-elles graves ?\nLes symptômes varient-ils selon l'âge ?",
"url": "https://questionsmedicales.fr/mesh/D002912?mesh_terms=Adenosine+Diphosphate#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Chrysosporium",
"description": "Comment prévenir les infections par Chrysosporium ?\nLes personnes immunodéprimées doivent-elles prendre des précautions ?\nLe port de gants est-il recommandé lors de manipulations ?\nLes vaccinations aident-elles à prévenir ces infections ?\nL'hygiène personnelle joue-t-elle un rôle dans la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D002912?mesh_terms=Adenosine+Diphosphate#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Chrysosporium",
"description": "Quels traitements sont efficaces contre Chrysosporium ?\nLes traitements varient-ils selon la gravité de l'infection ?\nCombien de temps dure le traitement antifongique ?\nDes effets secondaires sont-ils associés aux antifongiques ?\nLes infections par Chrysosporium nécessitent-elles une hospitalisation ?",
"url": "https://questionsmedicales.fr/mesh/D002912?mesh_terms=Adenosine+Diphosphate#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Chrysosporium",
"description": "Quelles complications peuvent survenir avec Chrysosporium ?\nLes infections par Chrysosporium peuvent-elles être mortelles ?\nComment les complications sont-elles gérées ?\nLes complications affectent-elles le pronostic ?\nLes infections récurrentes sont-elles possibles ?",
"url": "https://questionsmedicales.fr/mesh/D002912?mesh_terms=Adenosine+Diphosphate#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Chrysosporium",
"description": "Quels sont les principaux facteurs de risque d'infection ?\nLes personnes âgées sont-elles plus à risque ?\nLe diabète augmente-t-il le risque d'infection fongique ?\nLes traitements immunosuppresseurs sont-ils un facteur de risque ?\nLes voyages dans des zones tropicales augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D002912?mesh_terms=Adenosine+Diphosphate#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection par Chrysosporium ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen microscopique et la culture du champignon."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour identifier Chrysosporium ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de culture et des techniques moléculaires comme la PCR peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Les biopsies sont-elles nécessaires pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des biopsies peuvent être nécessaires pour confirmer l'infection fongique."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une infection par Chrysosporium ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure des lésions cutanées, des infections pulmonaires ou systémiques."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser des tests sérologiques pour le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests sérologiques ne sont généralement pas fiables pour Chrysosporium."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants d'une infection fongique ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, toux, éruptions cutanées et fatigue."
}
},
{
"@type": "Question",
"name": "Les infections cutanées par Chrysosporium sont-elles fréquentes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent provoquer des lésions cutanées et des démangeaisons."
}
},
{
"@type": "Question",
"name": "Comment se manifestent les infections pulmonaires ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles se manifestent par une toux persistante, des douleurs thoraciques et des difficultés respiratoires."
}
},
{
"@type": "Question",
"name": "Les infections systémiques sont-elles graves ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent être graves et nécessitent une attention médicale immédiate."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de l'âge et de l'état immunitaire."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections par Chrysosporium ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter l'exposition à des environnements humides et à des matériaux contaminés aide à prévenir."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées doivent-elles prendre des précautions ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles doivent éviter les environnements à risque et consulter un médecin régulièrement."
}
},
{
"@type": "Question",
"name": "Le port de gants est-il recommandé lors de manipulations ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le port de gants lors de la manipulation de terre ou de matériaux potentiellement contaminés est conseillé."
}
},
{
"@type": "Question",
"name": "Les vaccinations aident-elles à prévenir ces infections ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, il n'existe pas de vaccin spécifique contre les infections par Chrysosporium."
}
},
{
"@type": "Question",
"name": "L'hygiène personnelle joue-t-elle un rôle dans la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une bonne hygiène personnelle peut réduire le risque d'infections fongiques."
}
},
{
"@type": "Question",
"name": "Quels traitements sont efficaces contre Chrysosporium ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antifongiques comme l'itraconazole et le voriconazole sont souvent utilisés."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon la gravité de l'infection ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections légères peuvent être traitées par voie orale, tandis que les cas graves nécessitent une perfusion."
}
},
{
"@type": "Question",
"name": "Combien de temps dure le traitement antifongique ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La durée du traitement peut varier de plusieurs semaines à plusieurs mois selon la gravité."
}
},
{
"@type": "Question",
"name": "Des effets secondaires sont-ils associés aux antifongiques ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets secondaires comme des nausées, des éruptions cutanées et des problèmes hépatiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les infections par Chrysosporium nécessitent-elles une hospitalisation ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cela dépend de la gravité de l'infection; les cas graves peuvent nécessiter une hospitalisation."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec Chrysosporium ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des infections systémiques graves et des lésions pulmonaires."
}
},
{
"@type": "Question",
"name": "Les infections par Chrysosporium peuvent-elles être mortelles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en particulier chez les personnes immunodéprimées, elles peuvent être fatales."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles gérées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications nécessitent souvent des traitements antifongiques intensifs et un suivi médical."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles le pronostic ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la présence de complications peut aggraver le pronostic et prolonger la durée de traitement."
}
},
{
"@type": "Question",
"name": "Les infections récurrentes sont-elles possibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des infections récurrentes peuvent survenir, surtout chez les patients immunodéprimés."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'infection ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'immunodépression, le diabète et l'exposition à des environnements humides."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées ont un risque accru en raison d'un système immunitaire affaibli."
}
},
{
"@type": "Question",
"name": "Le diabète augmente-t-il le risque d'infection fongique ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diabète peut affaiblir le système immunitaire et augmenter le risque d'infections."
}
},
{
"@type": "Question",
"name": "Les traitements immunosuppresseurs sont-ils un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements immunosuppresseurs augmentent le risque d'infections fongiques."
}
},
{
"@type": "Question",
"name": "Les voyages dans des zones tropicales augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyages dans des zones tropicales peuvent exposer à des agents pathogènes fongiques."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 02/05/2025
Contenu vérifié selon les dernières recommandations médicales
6 publications dans cette catégorie
Affiliations :
College of Resources and Environment, Hunan Agricultural University, Changsha 410128, PR China. Electronic address: A.Chen@hunau.edu.cn.
4 publications dans cette catégorie
Affiliations :
School of Minerals Processing and Bioengineering, Key Laboratory of Biohydrometallurgy of Ministry of Education, Central South University, Changsha 410083, China. Electronic address: huliang2018@csu.edu.cn.
Publications dans "Chrysosporium" :
4 publications dans cette catégorie
Affiliations :
College of Chemistry and Environment Protection Engineering, Southwest Minzu University, Chengdu, 610041, PR China. Electronic address: yangst@pku.edu.cn.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
School of Minerals Processing and Bioengineering, Key Laboratory of Biohydrometallurgy of Ministry of Education, Central South University, Changsha 410083, China.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
Department of Applied Biological Chemistry, Faculty of Agriculture, Meijo University, Nagoya, Aichi 468-8502, Japan. Electronic address: moshimi@meijo-u.ac.jp.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
Biocatalysis and Biosensing Laboratory, Department of Food Science and Technology, BOKU-University of Natural Resources and Life Sciences, Muthgasse 18, 1190, Vienna, Austria.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
Biocatalysis and Biosensing Laboratory, Department of Food Science and Technology, BOKU-University of Natural Resources and Life Sciences, Muthgasse 18, 1190, Vienna, Austria.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
Biocatalysis and Biosensing Laboratory, Department of Food Science and Technology, BOKU-University of Natural Resources and Life Sciences, Muthgasse 18, 1190, Vienna, Austria. roland.ludwig@boku.ac.at.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
Faculty of Agriculture, Kyushu University, 6-10-1 Hakozaki, Higashi-ku, Fukuoka, 812-8581, Japan.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
College of Resources and Environment, Hunan Agricultural University, Changsha 410128, PR China.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
College of Resources and Environment, Hunan Agricultural University, Changsha 410128, PR China.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
College of Resources and Environment, Hunan Agricultural University, Changsha 410128, PR China.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
College of Environmental Science and Engineering, Hunan University and Key Laboratory of Environmental Biology and Pollution Control (Hunan University), Ministry of Education, Changsha 410082, PR China. Electronic address: zgming@hnu.edu.cn.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
College of Environmental Science and Engineering, Hunan University and Key Laboratory of Environmental Biology and Pollution Control (Hunan University), Ministry of Education, Changsha 410082, PR China.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
College of Resources and Environmental Science, Yunnan Agricultural University, Kunming 650201, China.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
College of Resources and Environmental Science, Yunnan Agricultural University, Kunming 650201, China. Electronic address: xuzhi9910@126.com.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
College of Environmental Science and Engineering, Hunan University, Changsha 410082, PR China; Key Laboratory of Environmental Biology and Pollution Control, Hunan University, Ministry of Education, Changsha 410082, PR China.
Publications dans "Chrysosporium" :
3 publications dans cette catégorie
Affiliations :
College of Environmental Science and Engineering, Hunan University, Changsha 410082, PR China; Key Laboratory of Environmental Biology and Pollution Control, Hunan University, Ministry of Education, Changsha 410082, PR China.
Publications dans "Chrysosporium" :
2 publications dans cette catégorie
Affiliations :
School of Minerals Processing and Bioengineering, Key Laboratory of Biohydrometallurgy of Ministry of Education, Central South University, Changsha 410083, China.
Publications dans "Chrysosporium" :
2 publications dans cette catégorie
Affiliations :
School of Minerals Processing and Bioengineering, Key Laboratory of Biohydrometallurgy of Ministry of Education, Central South University, Changsha 410083, China.
Publications dans "Chrysosporium" :
Adenosine diphosphate (ADP) ribosylation is an important post-translational modification (PTM) that plays a role in a wide variety of cellular processes. To study the enzymes responsible for the estab...
Recent guidelines regarding acute coronary syndrome (ACS) have advocated for use of prasugrel and ticagrelor over clopidogrel for acute coronary syndrome. However, analyses from multiple databases hav...
Usage of oral anticoagulants (OACs) or adenosine diphosphate inhibitors (ADPi) is known to increase the risk of bleeding. We aimed to investigate the impact of OAC and ADPi therapies on short-term out...
All adult patients hospitalized for TBI in Finland during 2005-2018 were retrospectively studied using a combination of national registries. Usage of pharmacy-purchased OACs and ADPi at the time of TB...
The study population included 57,056 persons (mean age 66 years) of whom 0.9% used direct OACs (DOACs), 7.1% vitamin K antagonists (VKA), and 2.3% ADPi. Patients with VKAs had higher case-fatality tha...
Preinjury use of VKA is associated with increases in short-term mortality and in need for ANOs after TBI. DOACs are associated with lower fatality than VKAs after TBI. ADPi were not independently asso...
This study provides Class II evidence that among adults with TBI, mortality was significantly increased in those using VKAs but not in those using DOACs or ADPi....
Nucleoside polyphosphate (NPP) anions are important for enzymatic activity and should be monitored by scientists in industry and medicine. By elucidating enzyme kinetics and processes, it aids in the ...
However, a discriminative turn-on fluorescent property is exhibited by non-fluorescent p-tertbutylcalix[4]arene modified 1,2,3-triazole containing bis-ruthenium polypyridyl complex (RL) upon the addit...
The calix[4]arene macrocycle's excellent size and binding cone conformation make it a good host-guest interface for the pyrophosphate anion and ADP. The bis-ruthenium polypyridyl complex's connection ...
Metastatic castration-resistant prostate cancer (mCRPC) is a heterogeneous disease with varying clinical and molecular subtypes. Almost one-third of patients have abnormalities in homologous recombina...
To compare radiographic progression-free survival (rPFS), overall survival (OS), and treatment-emergent adverse events (TEAEs) among patients with metastatic castrate-resistant prostate cancer (mCRPC)...
We conducted a systematic review/meta-analysis of all published Phase III randomised controlled trials using EMBASE, MEDLINE, and Cochrane (inception until 6 June 2023). Published full-text manuscript...
Three trials were identified: PROpel, MAGNITUDE, and TALAPRO-2. Compared to placebo/ARAT, the PARPi/ARAT combination was associated with a 35% rPFS improvement in the overall cohort (HR 0.65, 95% CI 0...
The addition of PARPi to ARAT in the first-line mCRPC setting is associated with rPFS benefits across subgroups, with the greatest magnitude of benefit in BRCA1/2m patients. OS benefits remain inconsi...
BRCA1 c.5096G>A (p. Arg1699Gln) (hereinafter BRCA1 R1699Q) is classified as a pathogenic genetic variant despite its lower penetrance of breast and ovarian cancers compared to other BRCA1 variants. Ho...
We present a case of stage IIIc high-grade primary peritoneal cancer in a 69-year-old woman with germline BRCA1 R1699Q variant. She received platinum-containing chemotherapy followed by surgery. Eight...
This is the first report of the clinical outcome of PARP inhibitor and platinum-containing chemotherapy in a patient with a BRCA1 R1699Q variant. Despite BRCA1 mutation and high GIS, used as indicator...
Nucleoside diphosphate kinases (NDPKs) are encoded by...
Several experimental studies have linked adenosine's neuroprotective role in cerebral ischemia. During ischemia, adenosine is formed due to intracellular ATP breakdown into ADP, further when phosphate...
Ion channel activation upon ligand gating triggers a myriad of biological events and, therefore, evolution of ligand gating mechanism is of fundamental importance. TRPM2, a typical ancient ion channel...